| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c24684033fba97d1ad845ce453a57e3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-38 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-30 |
| filingDate |
1993-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_991fbb22f5561a422f2f7cf590d94f36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4742b3d5b756d049b789d93682f7cf67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_807025c5b57c437490da2434d95233e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9b4a190d476f6893ad451a2cda1ee85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73fd81f831f82aa94961d9df33d4565b |
| publicationDate |
1993-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2089954-A1 |
| titleOfInvention |
4-amino-2-ureidopyrimidine-5-carboxamides, a process for the preparation thereof, pharmaceuticals containing these compounds, and the use thereof |
| abstract |
4-Amino-2-ureidopyrimidine-5-carboxamides, a process for the preparation thereof, pharmaceuticals containing these compounds, and the use thereof Compounds of the formula I (see formula I) in which R1 to R6 have the stated meanings, and the readily water-soluble salts of these compounds, and a process for the preparation thereof era described. The compounds are suitable for the treatment of lipid meta-bolism disorders which era beneficially influenced by a stimulation of the hepatic LDL receptor. Also described are compounds of the formula II (see formula II) and the salts thereof. |
| priorityDate |
1992-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |